[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE135044T1 - Faktor x-laci-hybridprotein - Google Patents

Faktor x-laci-hybridprotein

Info

Publication number
ATE135044T1
ATE135044T1 AT91870008T AT91870008T ATE135044T1 AT E135044 T1 ATE135044 T1 AT E135044T1 AT 91870008 T AT91870008 T AT 91870008T AT 91870008 T AT91870008 T AT 91870008T AT E135044 T1 ATE135044 T1 AT E135044T1
Authority
AT
Austria
Prior art keywords
laci
factor
hybrid protein
amino acid
acid sequence
Prior art date
Application number
AT91870008T
Other languages
English (en)
Inventor
Thomas James Girard
George John Broze Jr
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE135044T1 publication Critical patent/ATE135044T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91870008T 1990-01-25 1991-01-21 Faktor x-laci-hybridprotein ATE135044T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47028990A 1990-01-25 1990-01-25

Publications (1)

Publication Number Publication Date
ATE135044T1 true ATE135044T1 (de) 1996-03-15

Family

ID=23866994

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91870008T ATE135044T1 (de) 1990-01-25 1991-01-21 Faktor x-laci-hybridprotein

Country Status (8)

Country Link
EP (1) EP0439442B1 (de)
JP (1) JP2560150B2 (de)
AT (1) ATE135044T1 (de)
CA (1) CA2034881C (de)
DE (1) DE69117545T2 (de)
DK (1) DK0439442T3 (de)
ES (1) ES2086521T3 (de)
GR (1) GR3019877T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2049873C (en) * 1990-08-27 2001-12-04 Tze-Chein Wun Anticoagulant combination of laci and sulfated polysaccharides
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US5807980A (en) * 1992-07-13 1998-09-15 Corvas International, Inc. Bovine pancreatic trypsin inhibitor derived inhibitors of factor VIIa-tissue factor complex
US5863894A (en) * 1995-06-05 1999-01-26 Corvas International, Inc. Nematode-extracted anticoagulant protein
DE69535317T2 (de) * 1994-10-18 2007-06-21 Dendreon Corp., Seattle Aus nematoden extrahierte serinprotease-inhibitoren und die koagulation hemmende proteine
US5866542A (en) * 1994-10-18 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
CA2202351A1 (en) * 1994-10-18 1996-04-25 George Phillip Vlasuk Nematode-extracted serine protease inhibitors and anticoagulant proteins
US5945275A (en) * 1994-10-18 1999-08-31 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866543A (en) * 1995-06-05 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5872098A (en) * 1995-06-05 1999-02-16 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US5736364A (en) * 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
DK0866870T3 (da) * 1995-12-01 2003-06-23 Genentech Inc Vævsfaktor-Kunitz-domæne-fusionsproteiner som inhibitorer for faktor Vlla
WO1997033996A2 (en) 1996-03-11 1997-09-18 Bayer Corporation Human bikunin
US6159722A (en) 1997-12-03 2000-12-12 Boehringer Mannheim Gmbh Chimeric serine proteases
EP0927764B1 (de) * 1997-12-03 2004-05-26 Boehringer Mannheim Gmbh Chimäre Serinproteasen
CA2405525A1 (en) * 2000-04-12 2001-10-25 Principia Pharmaceutical Corporation Albumin fusion proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co cDNA of human tissue factor inhibitor

Also Published As

Publication number Publication date
GR3019877T3 (en) 1996-08-31
EP0439442B1 (de) 1996-03-06
JPH04211000A (ja) 1992-08-03
DK0439442T3 (da) 1996-07-08
DE69117545D1 (de) 1996-04-11
JP2560150B2 (ja) 1996-12-04
DE69117545T2 (de) 1996-10-31
EP0439442A2 (de) 1991-07-31
EP0439442A3 (en) 1992-05-27
CA2034881A1 (en) 1991-07-26
ES2086521T3 (es) 1996-07-01
CA2034881C (en) 2001-05-29

Similar Documents

Publication Publication Date Title
ATE135044T1 (de) Faktor x-laci-hybridprotein
ATE200783T1 (de) Neuartige peptidderivate
DE68927088D1 (de) Menschlicher Gefässpermeabilitätsfaktor
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
ATE81503T1 (de) N-(mercaptoalkyl)-omega-hydroxyalkylamide und ihre verwendung als reduktionsmittel in einem verfahren zur bleibenden gestaltung von haaren.
DK0625912T3 (da) Behandling af inflammatorisk tarmsygdom
FI883487A0 (fi) Ihmisen kudostekijäinhibiittorin DNA-klooni
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
ES551820A0 (es) Un procedimiento para la fabricacion de derivados peptidicos inhibidores de la renina y de las proteasas acidas
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
SE8901552D0 (sv) Acid addition salts of amidated or glycine, their preparation and use
DK627687A (da) Hirudinvariant
PT88383A (pt) Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
FI925696A0 (fi) Pao hirudinets aminosyrasekvens baserade trombininhibitorer
DK226889D0 (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
DE3769910D1 (de) Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung.
ATE151996T1 (de) Kit zur einführung eines fremdkörpers, der geeignet zur identifikation eines tieres ist
ATE80388T1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
MA23133A1 (fr) Derives d'acide d'acyloxyhexanoique .
DK0490383T3 (da) Peptider af HIV-gag-proteinet, fremstilling og anvendelse deraf
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
DK53290A (da) Syntetiske gaer-leader-peptider
DK288581A (da) Anvendelse af peptider som diagnost ikum

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee